Genus (GNS) Stock Rating Reaffirmed by Liberum Capital

Liberum Capital reaffirmed their hold rating on shares of Genus (LON:GNS) in a research report report published on Friday.

A number of other equities research analysts have also recently issued reports on GNS. Kepler Capital Markets upgraded shares of Genus to a buy rating and increased their target price for the stock from GBX 2,475 ($32.34) to GBX 2,630 ($34.37) in a research report on Thursday. Peel Hunt reiterated a hold rating on shares of Genus in a research report on Thursday.

Shares of Genus stock opened at GBX 2,246 ($29.35) on Friday. Genus has a 12-month low of GBX 1,652 ($21.59) and a 12-month high of GBX 2,597 ($33.93).

In other Genus news, insider Karim Bitar sold 5,920 shares of the firm’s stock in a transaction dated Monday, September 17th. The shares were sold at an average price of GBX 2,538 ($33.16), for a total value of £150,249.60 ($196,327.71).

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.

Recommended Story: Reverse Stock Split

Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply